Trademark: 90348702
Status Date
Monday, February 12, 2024
Filing Date
Monday, November 30, 2020
Published for Opposition
Tuesday, June 15, 2021
5 Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer
42 Pharmaceutical research and development; pharmaceutical product evaluation; testing of pharmaceuticals; development of pharmaceutical preparations and medicines; and scientific research in the fields of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
Feb 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 12, 2024
Sou Extension 5 Granted
Jan 22, 2024
Sou Extension 5 Filed
Feb 6, 2024
Case Assigned To Intent To Use Paralegal
Jan 22, 2024
Sou Teas Extension Received
Aug 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2023
Sou Extension 4 Granted
Aug 9, 2023
Sou Extension 4 Filed
Aug 9, 2023
Sou Teas Extension Received
Jan 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 19, 2023
Sou Extension 3 Granted
Jan 19, 2023
Sou Extension 3 Filed
Jan 19, 2023
Sou Teas Extension Received
Aug 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 4, 2022
Sou Extension 2 Granted
Aug 4, 2022
Sou Extension 2 Filed
Aug 4, 2022
Sou Teas Extension Received
Feb 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2022
Sou Extension 1 Granted
Feb 8, 2022
Sou Extension 1 Filed
Feb 8, 2022
Sou Teas Extension Received
Aug 10, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 15, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 15, 2021
Published For Opposition
May 26, 2021
Notification Of Notice Of Publication E-Mailed
May 12, 2021
Approved For Pub - Principal Register
May 6, 2021
Assigned To Examiner
Feb 4, 2021
New Application Office Supplied Data Entered
Dec 3, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
